Brind.
  1. Quoin Pharmaceuticals Ltd., which focuses on rare and orphan diseases, is developing investigational candidate QRX003 for Netherton Syndrome. Denise Carter serves as Co-Founder and COO.

Quoin Pharmaceuticals Ltd. featured Mandy Aldwin-Easton, who lives with Netherton Syndrome, in its NETHERTON NOW video series.

1 report, 1 independent Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Quoin Pharmaceuticals Ltd. featured Mandy Aldwin-Easton, who lives with Netherton Syndrome, in its NETHERTON NOW video series.

Who's involved

What this event is mainly about
Denise Carter

Keep exploring

Part of

Quoin Pharmaceuticals Ltd., which focuses on rare and orphan diseases, is developing investigational candidate QRX003 for Netherton Syndrome. Denise Carter serves as Co-Founder and COO. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • GlobeNewswireQuoin Pharmaceuticals Releases Fourth Episode in NETHERTON NOW Video Series Featuring International Patient Advocate Mandy Aldwin-Easton New Episode Highlights the Painful, Often Misunderstood Realit